1.14.16.2	L-tyrosine + a 5,6,7,8-tetrahydropteridine + O2 = L-dopa + a 4a-hydroxy-5,6,7,8-tetrahydropteridine	active binding site	438700	
1.14.16.2	L-tyrosine + a 5,6,7,8-tetrahydropteridine + O2 = L-dopa + a 4a-hydroxy-5,6,7,8-tetrahydropteridine	H-NMR analysis of conformation of the complex between phenylalanine, 6-methyltetrahydropterin and isoform hTH1	438703	
1.14.16.2	L-tyrosine + a 5,6,7,8-tetrahydropteridine + O2 = L-dopa + a 4a-hydroxy-5,6,7,8-tetrahydropteridine	ligand binding model, hTH1	438710	
1.14.16.2	L-tyrosine + a 5,6,7,8-tetrahydropteridine + O2 = L-dopa + a 4a-hydroxy-5,6,7,8-tetrahydropteridine	mechanism	438686, 438701, 438711	
1.14.16.2	L-tyrosine + a 5,6,7,8-tetrahydropteridine + O2 = L-dopa + a 4a-hydroxy-5,6,7,8-tetrahydropteridine	phosphorylation site of hTH1 is Ser-40	438708	
1.14.16.2	L-tyrosine + a 5,6,7,8-tetrahydropteridine + O2 = L-dopa + a 4a-hydroxy-5,6,7,8-tetrahydropteridine	requires Fe2+, activated by phosphorylation, catalysed by EC 2.7.1.128 [acetyl-CoA carboxylase] kinase	-	
1.14.16.2	L-tyrosine + a 5,6,7,8-tetrahydropteridine + O2 = L-dopa + a 4a-hydroxy-5,6,7,8-tetrahydropteridine	secondary structure and conformation analysis of phosphorylated and unphosphorylated isoform hTH1	438708	
1.14.16.2	L-tyrosine + a 5,6,7,8-tetrahydropteridine + O2 = L-dopa + a 4a-hydroxy-5,6,7,8-tetrahydropteridine	stereochemical analysis of ligand binding	438700